WEKO3
アイテム
Diagnostic Criteria and Laboratory Tests for Disseminated Intravascular Coagulation
http://hdl.handle.net/10076/11797
http://hdl.handle.net/10076/1179738515138-48ad-46dd-b8c1-23ce412208cd
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
30A15375.pdf (560.5 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2011-12-26 | |||||||||
| タイトル | ||||||||||
| タイトル | Diagnostic Criteria and Laboratory Tests for Disseminated Intravascular Coagulation | |||||||||
| 言語 | en | |||||||||
| 言語 | ||||||||||
| 言語 | eng | |||||||||
| キーワード | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | disseminated intravascular coagulation (DIC) | |||||||||
| キーワード | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | diagnostic criteria | |||||||||
| キーワード | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | hemostatic molecular marker | |||||||||
| 資源タイプ | ||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
| 資源タイプ | journal article | |||||||||
| 著者 |
Kaneko, Toshihiro
× Kaneko, Toshihiro
× Wada, Hideo
|
|||||||||
| 抄録 | ||||||||||
| 内容記述タイプ | Abstract | |||||||||
| 内容記述 | Disseminated intravascular coagulation (DIC) is associated with organ failure and it is often fatal condition. The main underlying diseases are infection, hematological malignancy and solid cancer. DIC is subclassified into overt DIC and nonovert DIC. The International Society on Thrombosis and Haemostasis (ISTH) and the Japanese Association for Acute Medicine (JAAM) published the diagnostic criteria for DIC after several recent clinical trials. These diagnostic criteria are modified versions of the Japanese Ministry of Health, Labor and Welfare (JMHLW) criteria. The JAAM diagnostic criteria demonstrated excellent sensitivity for mortality but low specificity. The mechanisms of onset of DIC vary based on the underlying diseases, and depend on tissue factor, cytokines, etc. Early diagnosis and early treatment for DIC are important, and the use of hemostatic molecular markers is necessary to successfully make an early and rapid diagnosis. The mortality of DIC might be improved by the administration of recombinant activated protein C or recombinant thrombomodulin. Further investigation to improve the mortality of DIC is required, including new methods for diagnosing and treating the disease. | |||||||||
| 書誌情報 |
Journal of clinical and experimental hematopathology : JCEH 巻 51, 号 2, p. 67-76, 発行日 2011-11-01 |
|||||||||
| ISSN | ||||||||||
| 収録物識別子タイプ | PISSN | |||||||||
| 収録物識別子 | 1880-9952 | |||||||||
| フォーマット | ||||||||||
| 内容記述タイプ | Other | |||||||||
| 内容記述 | application/pdf | |||||||||
| 著者版フラグ | ||||||||||
| 出版タイプ | VoR | |||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||
| 資源タイプ（三重大） | ||||||||||
| 値 | Journal Article / 学術雑誌論文 | |||||||||
